Thermal characterization of lovastatin in pharmaceutical formulations

Journal of Thermal Analysis and Calorimetry

Volumn 106, Issue 3, 2011, Pages 657-664

  Yoshida, M I ^a   Oliveira, M A ^b   Gomes, E C L ^a   Mussel, W N ^a   Castro, W V ^c   Soares, C D V ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Dosage form; Lovastatin; Pharmaceutical formulations; Thermal analysis

Indexed keywords

BASIC CONDITIONS; BASIC HYDROLYSIS; BUTYLHYDROXYANISOLE; CRYSTAL HABITS; DEGRADATION PRODUCTS; DOSAGE FORMS; LOVASTATIN; PHARMACEUTICAL FORMULATION; PHARMACEUTICAL INDUSTRY; PHYSICOCHEMICAL PROPERTY; THERMAL CHARACTERIZATION; UNIT CELLS;

DEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROLYSIS; MASS SPECTROMETRY; OPTICAL MICROSCOPY; THERMOANALYSIS; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION;

DRUG DOSAGE;

EID: 82955167908     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-011-1510-0     Document Type: Article

References (38)

1. Craig DQM, Reading M. Thermal analysis of pharmaceuticals. New York: CRC Press; 2007.
2. Wendlandt WW. Thermal analysis. 3rd ed. New York: Wiley; 1986.
3. Gabbott P. Principles and applications of thermal analysis. Oxford: Blackwell Publishing; 2008.
4. MR Caira A Foppoli ME Sangalli L Zema F Giordano 2004 Thermal and structural properties of ambroxol polymorphs J Therm Anal Calorim 77 653 662 10.1023/B:JTAN.0000039001.05945.42 1:CAS:528:DC%2BD2cXmvFSmtLY%3D
5. MN Freitas R Alves JR Matos JM Marchetti 2007 Thermal analysis applied in the osmotic tablets pre-formulation studies J Therm Anal Calorim 87 905 911 10.1007/s10973-006-7710-3 1:CAS:528:DC%2BD2sXis1Kntb4%3D
6. MA Hassan MS Salem MS Sueliman NM Najib 1997 Characterization of famotidine polymorphic forms Int J Pharm 149 227 232 10.1016/S0378-5173(97) 04872-2 1:CAS:528:DyaK2sXksFansb0%3D
7. M Laszcz B Kosmacinska K Korczak B Smigielska M Glice W Maruszak A Groman H Beczkowicz L Zelazko 2007 Study on compatibility of imatinib mesylate with pharmaceutical excipients J Therm Anal Calorim 88 305 310 10.1007/s10973-006- 8001-8 1:CAS:528:DC%2BD2sXlt1Kmsb8%3D
8. MLP Leitão J Canotilho MSC Cruz JC Pereira AT Souza JS Redinha 2002 Study of polymorphism from DSC melting curves: polymorphs of terfenadine J Therm Anal Calorim 68 397 412 10.1023/A:1016023315613
9. RO Macedo TG Nascimento JWE Veras 2002 Compatibility and stability studies of propranolol hydrochloride binary mixtures and tablets for TG and DSC-Photovisual J Therm Anal Calorim 67 483 489 10.1023/A:1013901332759 1:CAS:528:DC%2BD38Xit1CmsLs%3D
10. GGG Oliveira HG Ferraz JSR Matos 2005 Thermoanalytical study of glibenclamide and excipients J Therm Anal Calorim 79 267 270 10.1007/s10973-005-0047-5 1:CAS:528:DC%2BD2MXkt1Ciu70%3D
11. WW Porter III SC Elie AJ Matzger 2008 Polymorphism in carbamazepina cocrystals Cryst Growth Des 8 14 16 10.1021/cg701022e 1:CAS:528:DC%2BD1cXhtFWn
12. HK Stulzer PO Rodrigues TM Cardoso JSR Matos MAS Silva 2008 Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations J Therm Anal Calorim 91 323 328 10.1007/s10973-006-7935-1 1:CAS:528:DC%2BD1cXhsFansrc%3D
13. PR Hebert JM Gaziano KS Chan CH Hennekens 1997 Cholesterol lowering with statins drugs, risk of stroke and total mortality. An overview of randomized trial JAMA. 278 313 321 10.1001/jama.278.4.313 1:CAS:528:DyaK2sXltlWrurY%3D
14. C Baigent A Keech PM Kearney L Blackwell G Buck C Pollicino A Kirby T Sourjina R Peto R Collins R Semes 2005 Cholesterol treatment trialists (CTT) collaborators: efficacy and safety of cholesterol-lowering treatment: propective meta-analysis of data from 90,056 participants in 14 randomized trials of statins Lancet 366 1267 1278 10.1016/S0140-6736(05)67394-1 1:CAS:528: DC%2BD2MXhtVOlu7fM
15. S Ward JM Lloyd A Pandor M Holmes R Ara A Ryan W Yeo N Payne 2007 A systematic review and economic evaluation of statins for the prevention of coronary events Health Technol Assess 11 1 160
16. Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis. 1999;142:105-12.
17. J Rodenburg MN Vissers A Wiegman ASP Trotsenburg A Graaf E Groot FA Wijburg JJP Kastelein BA Hutten 2007 Statin treatment in children with familial hypercholesterolemia: the younger, the better Circulation. 116 664 668 10.1161/CIRCULATIONAHA.106.671016 1:CAS:528:DC%2BD2sXotlahtrs%3D
18. The Merck Index, Version 12:3 [Cd-Rom], Chapman & Hall, New York; 1999.
19. Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons: in pharmaceuticals, body fluids and postmortem material, vol. 2. 3rd ed. London: Pharmaceutical Press; 2004.
20. GL Amidon NA Kasim M Whitehouse C Ramachandran M Bermejo H Lennernas AS Hussain HE Junginger SA Stavchansky KK Midha VP Shah 2004 Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Mol Pharm. 1 85 96 10.1021/mp034006h
21. FDA-Food and Drug Administration. Guidance for industry. Dissolution testing of immediate release solid oral dosage forms. FDA, CDER, 1997.
22. F Balestrieri AD Magri AL Magri D Marini A Sacchini 1996 Application of differencial scanning calorimetry to the study of drug-excipient compatibility Thermochim Acta. 285 337 345 10.1016/0040-6031(96)02904-8 1:CAS:528: DyaK28XmtVyrurk%3D
23. GC Bazzo GC Segatto Silva 2005 Estudo termoanalítico de comprimidos revestidos contendo captopril através de termogravimetria (TG) e calorimetria exploratória diferencial (DSC) Braz J Pharm Sci. 41 315 322 1:CAS:528:DC%2BD28XitVOgurs%3D
24. LCS Cides AAS Araújo M Santos-Filho JR Matos 2006 Thermal behaviour, compatibility study and decomposition kinetics of glimepiride under isothermal and non-isothermal conditions J Therm Anal Calorim 84 441 445 10.1007/s10973-005-7131-8 1:CAS:528:DC%2BD28XksFektL8%3D
25. JP Carini C Pavei APC Silva G Machado AS Mexias VP Pereira SL Fialho P Mayorga 2009 Solid state evaluation of some thalidomide raw materials Int J Pharm. 372 17 23 10.1016/j.ijpharm.2008.12.034 1:CAS:528:DC%2BD1MXks12isL4%3D
26. NR Sperandeo A Karlsson S Cuffini S Pagola PW Stephens 2005 The crystal structure and physicochemical characteristics of 2-hydroxy-N-[3(5)-pyrazolyl]-1, 4-naphthoquinone-4-imine, a new antitrypanosomal compound AAPS Pharm. Sci Technol. 6 E655 E663 10.1208/pt060482
27. E Tedesco D Giron S Pfeffer 2002 Crystal structure elucidation and morphology study of pharmaceuticals in development Cryst Eng Commun. 4 393 400 1:CAS:528:DC%2BD38XmvFKrtrc%3D
28. The United States pharmacopeia. 31st ed. Rockville: United States Pharmacopeial Convention; 2008.
29. ICH Q2 (R1)-International conference on harmonization of technical requirements for the registration of drugs for human use. Validation of analytical procedures: text and methodology Q2(R1), Nov, 2005. http://www.ich.org/LOB/media/MEDIA417.pdf.
30. Snyder LR, Kirkland JJ, Glajch JL. Pratical HPLC method development. 2nd ed. New York: Wiley; 1997.
31. British pharmacopoeia 2007, Version 11.0 [Cd-Rom], London: The Stationery Office; 2007.
32. ICH Q1A (R2)-International conference on harmonization of technical requirements for the registration of drugs for human use. Stability testing of new drug substances and products Q1A(R2), Feb, 2003. http://www.ich.org/LOB/ media/MEDIA419.pdf.
33. Sundaram V, Kharkar MR, Yarraguntla SR, Gudipati S, Mandava VNBR. Amorphous simvastatin. US patent application publication, US 2006/0223882 A1, Oct. 5; 2006.
34. RO Macedo TG Nascimento CFS Aragão AP Barreto Gomes 2000 Application of thermal analysis in the characterization of anti-hypertensive drugs J Therm Anal Calorim 59 657 661 10.1023/A:1010176931264 1:CAS:528:DC%2BD3cXjt1ClsL8%3D
35. HF Ferguson DJ Frurip AJ Pastor LM Peerey LF Whiting 2000 A review of analytical applications of calorimetry Therm Acta. 363 1 21 10.1016/S0040- 6031(00)00498-6 1:CAS:528:DC%2BD3cXotVKqur4%3D
36. PO Rodrigues TFM Cardoso MAS Silva JR Matos 2005 Aplicação de técnicas termoanalíticas na caracterização, determinação da pureza e cinética de degradação da zidovudina (AZT) Acta Farm Bonaer 24 383 387 1:CAS:528:DC%2BD2MXht1amtbfO
37. AA Lueje J Pastine JA Squella LJ Nunez-Vergara 2005 Assessment of the hydrolytic degradation of lovastatin by HPLC J Chil Chem Soc. 50 639 646
38. Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons: in pharmaceuticals, body fluids and postmortem material, vol. 1. 3rd ed. London: Pharmaceutical Press; 2004.